{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:33:58Z","timestamp":1790688838531,"version":"4.1.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s42000-018-0033-5","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T09:43:32Z","timestamp":1528191812000},"page":"183-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Selenoproteins in human body: focus on thyroid pathophysiology"],"prefix":"10.1007","volume":"17","author":[{"given":"Ana","family":"Valea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Emanuela","family":"Georgescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"33_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jtemb.2016.08.004","volume":"39","author":"EG Varlamova","year":"2017","unstructured":"Varlamova EG, Cheremushkina IV (2017) Contribution of mammalian selenocysteine-containing proteins to carcinogenesis. J Trace Elem Med Biol 39:76\u201385","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"33_CR2","first-page":"239","volume":"9","author":"L Patrick","year":"2004","unstructured":"Patrick L (2004) Selenium biochemistry and cancer: a review of the literature. Altern Med Rev 9(3):239\u2013258","journal-title":"Altern Med Rev"},{"issue":"Suppl 1","key":"33_CR3","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1186\/1756-6614-8-S1-A23","volume":"8","author":"E Skowronska-Jozwiak","year":"2015","unstructured":"Skowronska-Jozwiak E (2015) The effect of selenium on thyroid physiology and pathology. Thyroid Res 8(Suppl 1):A23","journal-title":"Thyroid Res"},{"key":"33_CR4","doi-asserted-by":"publisher","unstructured":"Kieliszek M, B\u0142a\u017cejak S (2016) Current knowledge on the importance of selenium in food for living organisms: a review. Molecules 21(5). \n                    https:\/\/doi.org\/10.3390\/molecules21050609","DOI":"10.3390\/molecules21050609"},{"issue":"7","key":"33_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1089\/ars.2009.2973","volume":"12","author":"LV Papp","year":"2010","unstructured":"Papp LV, Holmgren A, Khanna KK (2010) Selenium and selenoproteins in health and disease. Antioxid Redox Signal 12(7):793\u2013795","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"33_CR6","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1080\/15476286.2014.996472","volume":"11","author":"JL Bubenik","year":"2014","unstructured":"Bubenik JL, Miniard AC, Driscoll DM (2014) Characterization of the UGA-recoding and SECIS-binding activities of SECIS-binding protein 2. RNA Biol 11(11):1402\u20131413","journal-title":"RNA Biol"},{"issue":"11","key":"33_CR7","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1096\/fj.201600424","volume":"30","author":"U Schweizer","year":"2016","unstructured":"Schweizer U, Fradejas-Villar N (2016) Why 21 ? The significance of selenoproteins for human health revealed by inborn errors of metabolism. FASEB J 30(11):3669\u20133681","journal-title":"FASEB J"},{"issue":"4","key":"33_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00018-016-2339-2","volume":"74","author":"CW Barrett","year":"2017","unstructured":"Barrett CW, Short SP, Williams CS (2017) Selenoproteins and oxidative stress-induced inflammatory tumorigenesis in the gut. Cell Mol Life Sci 74(4):607\u2013616","journal-title":"Cell Mol Life Sci"},{"key":"33_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.abb.2016.08.003","volume":"617","author":"R Brigelius-Floh\u00e9","year":"2017","unstructured":"Brigelius-Floh\u00e9 R, Floh\u00e9 L (2017) Selenium and redox signaling. Arch Biochem Biophys 617:48\u201359","journal-title":"Arch Biochem Biophys"},{"issue":"5624","key":"33_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1126\/science.1083516","volume":"300","author":"GV Kryukov","year":"2003","unstructured":"Kryukov GV, Castellano S, Novoselov SV et al (2003) Characterization of mammalian selenoproteomes. Science 300(5624):1439\u20131443","journal-title":"Science"},{"issue":"46","key":"33_CR11","doi-asserted-by":"publisher","first-page":"24036","DOI":"10.1074\/jbc.M116.756155","volume":"291","author":"VN Gladyshev","year":"2016","unstructured":"Gladyshev VN, Arn\u00e9r ES, Berry MJ et al (2016) Selenoprotein gene nomenclature. J Biol Chem 291(46):24036\u201324040","journal-title":"J Biol Chem"},{"issue":"5","key":"33_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.nut.2012.11.012","volume":"29","author":"M Kieliszek","year":"2013","unstructured":"Kieliszek M, B\u0142a\u017cejak S (2013) Selenium: significance, and outlook for supplementation. Nutrition 29(5):713\u2013718","journal-title":"Nutrition"},{"issue":"17","key":"33_CR13","doi-asserted-by":"publisher","first-page":"30047","DOI":"10.1016\/j.ceca.2017.05.001","volume":"S0143-4160","author":"MW Pitts","year":"2017","unstructured":"Pitts MW, Hoffmann PR (2017) Endoplasmic reticulum-resident selenoproteins as regulators of calcium signaling and homeostasis. Cell Calcium S0143-4160(17):30047\u201330047. \n                    https:\/\/doi.org\/10.1016\/j.ceca.2017.05.001","journal-title":"Cell Calcium"},{"issue":"3","key":"33_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00039.2013","volume":"94","author":"VM Labunskyy","year":"2014","unstructured":"Labunskyy VM, Hatfield DL, Gladyshev VN (2014) Selenoproteins: molecular pathways and physiological roles. Physiol Rev 94(3):739\u2013777","journal-title":"Physiol Rev"},{"issue":"5","key":"33_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10534-016-9959-8","volume":"29","author":"J Aaseth","year":"2016","unstructured":"Aaseth J, Alexander J, Bj\u00f8rklund G et al (2016) Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation. Biometals 29(5):827\u2013839","journal-title":"Biometals"},{"key":"33_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.abb.2015.06.024","volume":"595","author":"H Steinbrenner","year":"2016","unstructured":"Steinbrenner H, Speckmann B, Klotz LO (2016) Selenoproteins: antioxidant selenoenzymes and beyond. Arch Biochem Biophys 595:113\u2013119","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"33_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/iub.1455","volume":"68","author":"X Zhang","year":"2016","unstructured":"Zhang X, Zhang L, Zhu JH, Cheng WH (2016) Nuclear selenoproteins and genome maintenance. IUBMB Life 68(1):5\u201312","journal-title":"IUBMB Life"},{"issue":"9822","key":"33_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)61452-9","volume":"379","author":"MP Rayman","year":"2012","unstructured":"Rayman MP (2012) Selenium and human health. Lancet 379(9822):1256\u20131268","journal-title":"Lancet"},{"issue":"12","key":"33_CR19","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.2174\/0929867043365053","volume":"11","author":"M Soriano-Garcia","year":"2004","unstructured":"Soriano-Garcia M (2004) Organoselenium compounds as potential therapeutic and chemopreventive agents: a review. Curr Med Chem 11(12):1657\u20131669","journal-title":"Curr Med Chem"},{"key":"33_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.freeradbiomed.2013.07.012","volume":"65","author":"J Zhou","year":"2013","unstructured":"Zhou J, Huang K, Lei XG (2013) Selenium and diabetes-evidence from animal studies. Free Radic Biol Med 65:1548\u20131556","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"33_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/152308603764816569","volume":"5","author":"R Brigelius-Floh\u00e9","year":"2003","unstructured":"Brigelius-Floh\u00e9 R, Banning A, Schnurr K (2003) Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal 5(2):205\u2013215","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"33_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.2174\/1389203715666140608151134","volume":"15","author":"E Mangiapane","year":"2014","unstructured":"Mangiapane E, Pessione A, Pessione E (2014) Selenium and selenoproteins: an overview on different biological systems. Curr Protein Pept Sci 15(6):598\u2013607","journal-title":"Curr Protein Pept Sci"},{"key":"33_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.envint.2012.12.003","volume":"52","author":"HB Qin","year":"2013","unstructured":"Qin HB, Zhu JM, Liang L, Wang MS, Su H (2013) The bioavailability of selenium and risk assessment for human selenium poisoning in high-Se areas, China. Environ Int 52:66\u201374","journal-title":"Environ Int"},{"issue":"228","key":"33_CR24","first-page":"348","volume":"38","author":"K Lacka","year":"2015","unstructured":"Lacka K, Szeliga A (2015) Significance of selenium in thyroid physiology and pathology. Pol Merkur Lekarski 38(228):348\u2013353","journal-title":"Pol Merkur Lekarski"},{"issue":"3","key":"33_CR25","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3390\/molecules18033292","volume":"18","author":"Y Mehdi","year":"2013","unstructured":"Mehdi Y, Hornick JL, Istasse L, Dufrasne I (2013) Selenium in the environment, metabolism and involvement in body functions. Molecules 18(3):3292\u20133311","journal-title":"Molecules"},{"key":"33_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jtemb.2015.07.005","volume":"32","author":"AP Kipp","year":"2015","unstructured":"Kipp AP, Strohm D, Brigelius-Floh\u00e9 R et al (2015) Revised reference values for selenium intake. J Trace Elem Med Biol 32:195\u2013199","journal-title":"J Trace Elem Med Biol"},{"issue":"2\u20134","key":"33_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000332762","volume":"59","author":"B Roman Vi\u00f1as","year":"2011","unstructured":"Roman Vi\u00f1as B, Ribas Barba L et al (2011) Projected prevalence of inadequate nutrient intakes in Europe. Ann Nutr Metab 59(2\u20134):84\u201395. \n                    https:\/\/doi.org\/10.1159\/000332762","journal-title":"Ann Nutr Metab"},{"key":"33_CR28","doi-asserted-by":"publisher","unstructured":"Olza J, Aranceta-Bartrina J, Gonz\u00e1lez-Gross M et al (2017) Reported dietary intake and food sources of zinc, selenium, and vitamins A, E and C in the Spanish population: findings from the ANIBES study. Nutrients 9(7). \n                    https:\/\/doi.org\/10.3390\/nu9070697","DOI":"10.3390\/nu9070697"},{"issue":"11","key":"33_CR29","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1073\/pnas.1611576114","volume":"114","author":"GD Jolnes","year":"2017","unstructured":"Jolnes GD, Droz B, Greve P, Gottschalk P, Poffet D, McGrath SP, Seneviratne SI, Smith P, Winkel LH (2017) Selenium deficiency risk predicted to increase under future climate change. Proc Natl Acad Sci U S A 114(11):2848\u20132853. \n                    https:\/\/doi.org\/10.1073\/pnas.1611576114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"33_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/1871530315666150619094242","volume":"15","author":"E Guastamacchia","year":"2015","unstructured":"Guastamacchia E, Giagulli VA, Licchelli B, Triggiani V (2015) Selenium and iodine in autoimmune thyroiditis. Endocr Metab Immune Disord Drug Targets 15(4):288\u2013292","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"33_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrendo.2011.174","volume":"8","author":"L Schomburg","year":"2011","unstructured":"Schomburg L (2011) Selenium, selenoproteins and the thyroid gland. Nat Rev Endocrinology 8(3):160\u2013171","journal-title":"Nat Rev Endocrinology"},{"issue":"6","key":"33_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3109\/10715762.2015.1018247","volume":"49","author":"L Carroll","year":"2015","unstructured":"Carroll L, Davies MJ, Pattison DI (2015) Reaction of low-molecular-mass organoselenium compounds (and their sulphur analogues) with inflammation-associated oxidants. Free Radic Res 49(6):750\u2013767","journal-title":"Free Radic Res"},{"issue":"3","key":"33_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/15592294.2015.1013792","volume":"10","author":"B Speckmann","year":"2015","unstructured":"Speckmann B, Grune T (2015) Epigenetic effects of selenium and their implications for health. Epigenetics 10(3):179\u2013190","journal-title":"Epigenetics"},{"issue":"3","key":"33_CR34","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1530\/JME-15-0156","volume":"55","author":"U Schweizer","year":"2015","unstructured":"Schweizer U, Steegborn C (2015) New insights into the structure and mechanism of iodothyronine deiodinases. J Mol Endocrinol 55(3):R37\u2013R52","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"33_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/nu5020340","volume":"5","author":"J Joseph","year":"2013","unstructured":"Joseph J, Loscalzo J (2013) Selenistasis: epistatic effects of selenium on cardiovascular phenotype. Nutrients 5(2):340\u2013358","journal-title":"Nutrients"},{"issue":"1\u20133","key":"33_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12011-014-9992-9","volume":"159","author":"RB Jain","year":"2014","unstructured":"Jain RB (2014) Thyroid function and serum copper, selenium, and zinc in general U.S. population. Biol Trace Elem Res 159(1\u20133):87\u201398","journal-title":"Biol Trace Elem Res"},{"key":"33_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000355288","volume":"2","author":"E Rijntjes","year":"2013","unstructured":"Rijntjes E, Scholz PM, Mugesh G, Kohrle J (2013) Se- and se-based thiouracil and methimazole analogues exert different inhibitory mechanisms on type 1 and type 2 deiodinases. Eur Thyroid J 2:252\u2013258","journal-title":"Eur Thyroid J"},{"issue":"29","key":"33_CR38","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1073\/pnas.1323873111","volume":"111","author":"U Schweizer","year":"2014","unstructured":"Schweizer U, Schlicker C, Braun D, K\u00f6hrle J, Steegborn C (2014) Crystal structure of mammalian selenocysteine-dependent iodothyronine deiodinase suggests a peroxiredoxin-like catalytic mechanism. Proc Natl Acad Sci U S A 111(29):10526\u201310531","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"33_CR39","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1002\/anie.201601116","volume":"55","author":"S Mondal","year":"2016","unstructured":"Mondal S, Raja K, Schweizer U, Mugesh G (2016) Chemistry and biology in the biosynthesis and action of thyroid hormones. Angew Chem Int Ed Engl 55(27):7606\u20137630","journal-title":"Angew Chem Int Ed Engl"},{"key":"33_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fendo.2014.00215","volume":"5","author":"D Ciavardelli","year":"2014","unstructured":"Ciavardelli D, Bellomo M, Crescimanno C, Vella V (2014) Type 3 deiodinase: role in cancer growth, stemness, and metabolism. Front Endocrinol (Lausanne) 5:215. \n                    https:\/\/doi.org\/10.3389\/fendo.2014.00215\n                    \n                   eCollection 2014","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"33_CR41","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1210\/en.2011-1246","volume":"152","author":"Y Tanguy","year":"2011","unstructured":"Tanguy Y, Falluel-Morel A, Arthaud S et al (2011) The PACAP-regulated gene selenoprotein T is highly induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes. Endocrinology 152(11):4322\u20134335","journal-title":"Endocrinology"},{"issue":"3","key":"33_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2174\/187153009789044392","volume":"9","author":"V Triggiani","year":"2009","unstructured":"Triggiani V, Tafaro E, Giagulli VA et al (2009) Role of iodine, selenium and other micronutrients in thyroid function and disorders. Endocr Metab Immune Disord Drug Targets 9(3):277\u2013294","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"33_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/1574884711308020002","volume":"8","author":"M Puig-Domingo","year":"2013","unstructured":"Puig-Domingo M, Vila L (2013) The implications of iodine and its supplementation during pregnancy in fetal brain development. Curr Clin Pharmacol 8(2):97\u2013109","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"33_CR44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/cen.12284","volume":"80","author":"SA Eskes","year":"2014","unstructured":"Eskes SA, Endert E, Fliers E et al (2014) Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol 80(3):444\u2013451","journal-title":"Clin Endocrinol"},{"issue":"6","key":"33_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1530\/EJE-15-0069","volume":"172","author":"KH Winther","year":"2015","unstructured":"Winther KH, Bonnema SJ, Cold F et al (2015) Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population. Eur J Endocrinol 172(6):657\u2013667","journal-title":"Eur J Endocrinol"},{"key":"33_CR46","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1186\/1471-2458-13-1153","volume":"13","author":"Y Liu","year":"2013","unstructured":"Liu Y, Huang H, Zeng J, Sun C (2013) Thyroid volume, goiter prevalence, and selenium levels in an iodine-sufficient area: a cross-sectional study. BMC Public Health 13:1153","journal-title":"BMC Public Health"},{"key":"33_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1530\/EJE-10-1026","volume":"164","author":"LB Rasmussen","year":"2011","unstructured":"Rasmussen LB, Schomburg L, Kohrle J et al (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol 164:585\u2013590","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"33_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.14310\/horm.2002.1246","volume":"8","author":"J Doupis","year":"2009","unstructured":"Doupis J, Stavrianos C, Saltiki K et al (2009) Thyroid volume, selenium levels and nutritional habits in a rural region in Albania. Hormones (Athens) 8(4):296\u20132302","journal-title":"Hormones (Athens)"},{"issue":"4","key":"33_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40618-015-0391-7","volume":"39","author":"M Knobel","year":"2016","unstructured":"Knobel M (2016) Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters. J Endocrinol Investig 39(4):357\u2013373","journal-title":"J Endocrinol Investig"},{"issue":"11","key":"33_CR50","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2015-2222","volume":"100","author":"Q Wu","year":"2015","unstructured":"Wu Q, Rayman MP, Hongjun LV et al (2015) Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 100(11):4037\u20134047","journal-title":"J Clin Endocrinol Metab"},{"key":"33_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fendo.2017.00050","volume":"8","author":"SM Ferrari","year":"2017","unstructured":"Ferrari SM, Fallahi P, Antonelli A, Benvenga S (2017) Environmental issues in thyroid diseases. Front Endocrinol (Lausanne) 8:50. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.00050\n                    \n                   eCollection 2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"33_CR52","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11154-016-9361-4","volume":"17","author":"P Fallahi","year":"2016","unstructured":"Fallahi P, Ferrari SM, Vita R, Benvenga S, Antonelli A (2016) The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders. Rev Endocr Metab Disord 17(4):529\u2013535","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"33_CR53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.autrev.2014.10.008","volume":"14","author":"F D'Aurizio","year":"2015","unstructured":"D'Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R (2015) Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev 14(5):363\u2013369","journal-title":"Autoimmun Rev"},{"issue":"3","key":"33_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ejcn.2014.265","volume":"69","author":"G Muscogiuri","year":"2015","unstructured":"Muscogiuri G, Tirabassi G et al (2015) Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr 69(3):291\u2013296","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"33_CR55","first-page":"51","volume":"20","author":"MI Liontiris","year":"2017","unstructured":"Liontiris MI, Mazokopakis EE (2017) A concise review of Hashimoto thyroiditis (HT) and the importance of iodide, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients. Points that need more investigation. Hell J Nucl Med 20(1):51\u201356","journal-title":"Hell J Nucl Med"},{"issue":"5","key":"33_CR56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/thy.2016.0635","volume":"27","author":"S Hu","year":"2017","unstructured":"Hu S, Rayman MP (2017) Multiple nutritional factors and the risk of Hashimoto\u2019s thyroiditis. Thyroid 27(5):597\u2013610","journal-title":"Thyroid"},{"issue":"10","key":"33_CR57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1055\/s-0035-1559631","volume":"47","author":"LH Duntas","year":"2015","unstructured":"Duntas LH (2015) The role of iodine and selenium in autoimmune thyroiditis. Horm Metab Res 47(10):721\u2013726","journal-title":"Horm Metab Res"},{"key":"33_CR58","doi-asserted-by":"publisher","unstructured":"Yu L, Zhou L, Xu E et al (2017) Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis. J Endocrinol Investig. \n                    https:\/\/doi.org\/10.1007\/s40618-017-0693-z","DOI":"10.1007\/s40618-017-0693-z"},{"issue":"5","key":"33_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/07315724.2014.926161","volume":"34","author":"S Mahmoodianfard","year":"2015","unstructured":"Mahmoodianfard S, Vafa M, Golgiri F et al (2015) Effects of zinc and selenium supplementation on thyroid function in overweight and obese hypothyroid female patients: a randomized double-blind controlled trial. J Am Coll Nutr 34(5):391\u2013399","journal-title":"J Am Coll Nutr"},{"issue":"6","key":"33_CR60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00420-013-0895-4","volume":"87","author":"O Parshukova","year":"2014","unstructured":"Parshukova O, Potolitsyna N, Shadrina V, Chernykh A, Bojko E (2014) Features of selenium metabolism in humans living under the conditions of North European Russia. Int Arch Occup Environ Health 87(6):607\u2013614","journal-title":"Int Arch Occup Environ Health"},{"issue":"15","key":"33_CR61","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1089\/ars.2014.6228","volume":"24","author":"SG Leoni","year":"2016","unstructured":"Leoni SG, Sastre-Perona A, De la Vieja A, Santisteban P (2016) Selenium increases thyroid-stimulating hormone-induced sodium\/iodide symporter expression through thioredoxin\/apurinic\/apyrimidinic endonuclease 1-dependent regulation of paired box 8 binding activity. Antioxid Redox Signal 24(15):855\u2013866","journal-title":"Antioxid Redox Signal"},{"key":"33_CR62","doi-asserted-by":"publisher","unstructured":"Mondal S, Mugesh G (2017) Novel thyroid hormone analogues, enzyme inhibitors and mimetics, and their action. Mol Cell Endocrinol. \n                    https:\/\/doi.org\/10.1016\/j.mce.2017.04.006","DOI":"10.1016\/j.mce.2017.04.006"},{"key":"33_CR63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev-nutr-071714-034250","volume":"35","author":"RF Burk","year":"2015","unstructured":"Burk RF, Hill KE (2015) Regulation of selenium metabolism and transport. Annu Rev Nutr 35:109\u2013134","journal-title":"Annu Rev Nutr"},{"issue":"13","key":"33_CR64","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1074\/jbc.M114.549014","volume":"289","author":"S Kurokawa","year":"2014","unstructured":"Kurokawa S, Bellinger FP, Hill KE, Burk RF, Berry MJ (2014) Isoform-specific binding of selenoprotein P to the \u03b2-propeller domain of apolipoprotein E receptor 2 mediates selenium supply. J Biol Chem 289(13):9195\u20139207","journal-title":"J Biol Chem"},{"issue":"8","key":"33_CR65","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1096\/fj.14-252874","volume":"28","author":"RF Burk","year":"2014","unstructured":"Burk RF, Hill KE, Motley AK et al (2014) Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. FASEB J 28(8):3579\u20133588","journal-title":"FASEB J"},{"issue":"6","key":"33_CR66","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3390\/nu5061937","volume":"5","author":"J Mao","year":"2013","unstructured":"Mao J, Teng W (2013) The relationship between selenoprotein P and glucose metabolism in experimental studies. Nutrients 5(6):1937\u20131948","journal-title":"Nutrients"},{"key":"33_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2014.01.010","volume":"69","author":"S Kurokawa","year":"2014","unstructured":"Kurokawa S, Eriksson S, Rose KL et al (2014) Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1. Free Radic Biol Med 69:67\u201376","journal-title":"Free Radic Biol Med"},{"key":"33_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jtemb.2015.10.003","volume":"34","author":"M Nourbakhsh","year":"2016","unstructured":"Nourbakhsh M, Ahmadpour F, Chahardoli B et al (2016) Selenium and its relationship with selenoprotein P and glutathioneperoxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism. J Trace Elem Med Biol 34:10\u201314","journal-title":"J Trace Elem Med Biol"},{"issue":"10","key":"33_CR69","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s40618-015-0285-8","volume":"38","author":"CR Farias de","year":"2015","unstructured":"de Farias CR, Cardoso BR, de Oliveira GM (2015) A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J Endocrinol Investig 38(10):1065\u20131074","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"33_CR70","first-page":"6","volume":"10","author":"EE Mazokopakis","year":"2007","unstructured":"Mazokopakis EE, Chatzipavlidou V (2007) Hashimoto\u2019s thyroiditis and the role of selenium. Current concepts. Hell J Nucl Med 10(1):6\u20138","journal-title":"Hell J Nucl Med"},{"issue":"4","key":"33_CR71","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jcem.87.4.8421","volume":"87","author":"R G\u00e4rtner","year":"2002","unstructured":"G\u00e4rtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87(4):1687\u20131691","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"33_CR72","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40618-016-0535-4","volume":"40","author":"D Esposito","year":"2017","unstructured":"Esposito D, Rotondi M, Accardo G et al (2017) Influence of short-term selenium supplementation on the natural course of Hashimoto's thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial. J Endocrinol Investig 40(1):83\u201389","journal-title":"J Endocrinol Investig"},{"key":"33_CR73","doi-asserted-by":"publisher","first-page":"CD010223","DOI":"10.1002\/14651858.CD010223.pub2","volume":"6","author":"EJ Zuuren van","year":"2013","unstructured":"van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H (2013) Selenium supplementation for Hashimoto\u2019s thyroiditis. Cochrane Database Syst Rev 6:CD010223. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010223.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"33_CR74","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5603\/EP.2016.0064","volume":"67","author":"I Pirola","year":"2016","unstructured":"Pirola I, Gandossi E, Agosti B, Delbarba A, Cappelli C (2016) Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis. Endokrynol Pol 67(6):567\u2013571","journal-title":"Endokrynol Pol"},{"issue":"12","key":"33_CR75","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1089\/thy.2016.0256","volume":"26","author":"J Wichman","year":"2016","unstructured":"Wichman J, Winther KH, Bonnema SJ, Heged\u00fcs L (2016) Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 26(12):1681\u20131692","journal-title":"Thyroid"},{"issue":"10","key":"33_CR76","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1210\/jc.2014-1322","volume":"99","author":"T Watt","year":"2014","unstructured":"Watt T, Cramon P, Heged\u00fcs L et al (2014) The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab 99(10):3708\u20133717","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"33_CR77","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.kjms.2016.06.006","volume":"32","author":"H Bektas Uysal","year":"2016","unstructured":"Bektas Uysal H, Ayhan M (2016) Autoimmunity affects health-related quality of life in patients with Hashimoto\u2019s thyroiditis. Kaohsiung J Med Sci 32(8):427\u2013433","journal-title":"Kaohsiung J Med Sci"},{"issue":"8","key":"33_CR78","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1089\/thy.2016.0044","volume":"26","author":"P Cramon","year":"2016","unstructured":"Cramon P, Winther KH, Watt T et al (2016) Quality-of-life impairments persist six months after treatment of Graves\u2019 hyperthyroidism and toxic nodular goiter: a prospective cohort study. Thyroid 26(8):1010\u20131018","journal-title":"Thyroid"},{"issue":"3","key":"33_CR79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/thy.2014.0433","volume":"25","author":"P Cramon","year":"2015","unstructured":"Cramon P, Bonnema SJ, Bjorner JB et al (2015) Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population. Thyroid 25(3):284\u2013291","journal-title":"Thyroid"},{"issue":"1","key":"33_CR80","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000443609","volume":"5","author":"SL Rasmussen","year":"2016","unstructured":"Rasmussen SL, Rejnmark L, Ebbeh\u00f8j E et al (2016) High level of agreement between electronic and paper mode of administration of a Thyroid-Specific Patient-Reported Outcome, ThyPRO. Eur Thyroid J 5(1):65\u201372","journal-title":"Eur Thyroid J"},{"key":"33_CR81","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12955-015-0362-x","volume":"13","author":"W Muehlhausen","year":"2015","unstructured":"Muehlhausen W, Doll H, Quadri N et al (2015) Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes 13:167. \n                    https:\/\/doi.org\/10.1186\/s12955-015-0362-x","journal-title":"Health Qual Life Outcomes"},{"key":"33_CR82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1745-6215-15-115","volume":"15","author":"KH Winther","year":"2014","unstructured":"Winther KH, Watt T, Bj\u00f8rner JB et al (2014) The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 15:115","journal-title":"Trials"},{"issue":"1","key":"33_CR83","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-09-0521","volume":"162","author":"T Watt","year":"2010","unstructured":"Watt T, Heged\u00fcs L, Groenvold M et al (2010) Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 162(1):161\u2013167","journal-title":"Eur J Endocrinol"},{"key":"33_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2277-9175.223735","volume":"7","author":"A Kachouei","year":"2018","unstructured":"Kachouei A, Rezvanian H, Amini M, Aminorroaya A, Moradi E (2018) The effect of levothyroxine and selenium versus levothyroxine alone on reducing the level of anti-thyroid peroxidase antibody in autoimmune hypothyroidism patients. Adv Biomed Res 7:1","journal-title":"Adv Biomed Res"},{"issue":"2","key":"33_CR85","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12020-016-1098-z","volume":"55","author":"KH Winther","year":"2017","unstructured":"Winther KH, Wichman JE, Bonnema SJ, Heged\u00fcs L (2017) Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine 55(2):376\u2013385","journal-title":"Endocrine"},{"issue":"5","key":"33_CR86","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4103\/2230-8210.190555","volume":"20","author":"SK Chakrabarti","year":"2016","unstructured":"Chakrabarti SK, Ghosh S, Banerjee S, Mukherjee S, Chowdhury S (2016) Oxidative stress in hypothyroid patients and the role of antioxidant supplementation. Indian J Endocrinol Metab 20(5):674\u2013678","journal-title":"Indian J Endocrinol Metab"},{"key":"33_CR87","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000363162","volume":"26","author":"G Radetti","year":"2014","unstructured":"Radetti G (2014) Clinical aspects of Hashimoto\u2019s thyroiditis. Endocr Dev 26:158\u2013170","journal-title":"Endocr Dev"},{"issue":"2","key":"33_CR88","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3803\/EnM.2016.31.2.213","volume":"31","author":"WM Wiersinga","year":"2016","unstructured":"Wiersinga WM (2016) Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease. Endocrinol Metab (Seoul) 31(2):213\u2013222","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"10 Suppl","key":"33_CR89","first-page":"8","volume":"36","author":"D Nacamulli","year":"2013","unstructured":"Nacamulli D, Petricca D, Mian C (2013) Selenium and autoimmune thyroiditis. J Endocrinol Investig 36(10 Suppl):8\u201314","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"33_CR90","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12020-014-0477-6","volume":"48","author":"LH Duntas","year":"2015","unstructured":"Duntas LH, Benvenga S (2015) Selenium: an element for life. Endocrine 48(3):756\u2013775. \n                    https:\/\/doi.org\/10.1007\/s12020-014-0477-6","journal-title":"Endocrine"},{"issue":"4","key":"33_CR91","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/cen.12185","volume":"79","author":"I Bullow Pedersen","year":"2013","unstructured":"Bullow Pedersen I, Knudsen N et al (2013) Serum selenium is low in newly diagnosed Graves\u2019s disease: a population-based study. Clin Endocrinol 79(4):584\u2013590","journal-title":"Clin Endocrinol"},{"issue":"6","key":"33_CR92","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/cen.12392","volume":"80","author":"JJ Khong","year":"2014","unstructured":"Khong JJ, Goldstein RF, Sanders KM et al (2014) Serum selenium status in Graves\u2019s disease with and without orbitopathy: a case-control study. Clin Endcrinol (Oxf) 80(6):905\u2013910","journal-title":"Clin Endcrinol (Oxf)"},{"issue":"3","key":"33_CR93","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/157340607780620662","volume":"3","author":"T Wertenbruch","year":"2007","unstructured":"Wertenbruch T, Wilenberg HS, Sagert C et al (2007) Serum selenium in patients with remission and relapse of Graves\u2019s disease. Med Chem 3(3):281\u2013284","journal-title":"Med Chem"},{"issue":"1","key":"33_CR94","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000442440","volume":"5","author":"N Dehina","year":"2016","unstructured":"Dehina N, Hofmann PJ, Behrends T, Eckstein A, Schomburg L (2016) Lack of association between selenium status and disease severity and activity in patients with Graves\u2019 ophthalmopathy. Eur Thyroid J 5(1):57\u201364","journal-title":"Eur Thyroid J"},{"issue":"1","key":"33_CR95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","volume":"100","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, McNab AA, Ebeling PR, Craig JE, Selva D (2016) Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol 100(1):142\u2013150","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"33_CR96","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1210\/jc.2017-01736","volume":"102","author":"GJ Kahaly","year":"2017","unstructured":"Kahaly GJ, Riedl M, K\u00f6nig J, Diana T, Schomburg L (2017) Double-blind, placebo- controlled, randomized trial of selenium in graves hyperthyroidism. J Clin Endocrinol Metab 102(11):4333\u20134341. \n                    https:\/\/doi.org\/10.1210\/jc.2017-01736","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"33_CR97","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1055\/s-0042-110491","volume":"48","author":"L Wang","year":"2016","unstructured":"Wang L, Wang B, Chen SR et al (2016) Effect of selenium supplementation on recurrent hyperthyroidism caused by Graves\u2019 disease: a prospective pilot study. Horm Metab Res 48(9):559\u2013564","journal-title":"Horm Metab Res"},{"key":"33_CR98","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1745-6215-14-119","volume":"14","author":"T Watt","year":"2013","unstructured":"Watt T, Cramon P, Bjorner B et al (2013) Selenium supplementation for patients with Graves\u2019 hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 14:119. \n                    https:\/\/doi.org\/10.1186\/1745-6215-14-119","journal-title":"Trials"},{"issue":"3","key":"33_CR99","first-page":"344","volume":"11","author":"P Cramon","year":"2014","unstructured":"Cramon P, Rasmussen \u00c5K, Bonnema SJ et al (2014) Development and implementation of PROgmatic: a clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes. ClinTrials 11(3):344\u2013354","journal-title":"ClinTrials"},{"issue":"2","key":"33_CR100","first-page":"365","volume":"7","author":"A Dharmasena","year":"2014","unstructured":"Dharmasena A (2014) Selenium supplementation in thyroid associated ophthalmopathy: an update. Int J Ophthalmol 7(2):365\u2013375","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"33_CR101","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/mutage\/get050","volume":"28","author":"S Gupta","year":"2013","unstructured":"Gupta S, Jaworska-Bieniek K, Lubinski J, Jakubowska A (2013) Can selenium be a modifier of cancer risk in CHEK2 mutation carriers? Mutagenesis 28(6):625\u2013629","journal-title":"Mutagenesis"},{"issue":"3","key":"33_CR102","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ijc.29426","volume":"137","author":"M Sio\u0142ek","year":"2015","unstructured":"Sio\u0142ek M, Cybulski C, G\u0105sior-Perczak D et al (2015) CHEK2 mutations and the risk of papillary thyroid cancer. Int J Cancer 137(3):548\u2013552","journal-title":"Int J Cancer"},{"key":"33_CR103","doi-asserted-by":"publisher","unstructured":"Nettore IC, De Nisco E, Desiderio S et al (2017) Selenium supplementation modulates apoptotic processes in thyroid follicular cells. Biofactors. \n                    https:\/\/doi.org\/10.1002\/biof.1351","DOI":"10.1002\/biof.1351"},{"key":"33_CR104","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/ije\/18.1.45","volume":"18","author":"E Glattre","year":"1989","unstructured":"Glattre E, Thomassen Y, Thoresen SO et al (1989) Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 18:45\u201349","journal-title":"Int J Epidemiol"},{"issue":"2","key":"33_CR105","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12011-015-0304-9","volume":"167","author":"F Shen","year":"2015","unstructured":"Shen F, Cai WS, Li JL, Feng Z, Cao J, Xu B (2015) The association between serum levels of selenium, copper, and magnesium with thyroid cancer: a meta-analysis. Biol Trace Elem Res 167(2):225\u2013235","journal-title":"Biol Trace Elem Res"},{"issue":"10 Suppl","key":"33_CR106","first-page":"1","volume":"36","author":"J K\u00f6hrle","year":"2013","unstructured":"K\u00f6hrle J (2013) Pathophysiological relevance of selenium. J Endocrinol Investig 36(10 Suppl):1\u20137","journal-title":"J Endocrinol Investig"},{"issue":"7","key":"33_CR107","first-page":"10993","volume":"8","author":"H Mao","year":"2015","unstructured":"Mao H, Cui R, Wang X (2015) Association analysis of selenoprotein S polymorphisms in Chinese Han with susceptibility to gastric cancer. Int J Clin Exp Med 8(7):10993\u201310999","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"33_CR108","doi-asserted-by":"publisher","first-page":"e71411","DOI":"10.1371\/journal.pone.0071411","volume":"8","author":"L Huang","year":"2013","unstructured":"Huang L, Shi Y, Lu F et al (2013) Association study of polymorphism on selenoprotein genes and Kashin-Beck disease and serum selenium\/iodine concentration in a Tibetan population. PlosONE 8(8):e71411","journal-title":"PlosONE"},{"issue":"1","key":"33_CR109","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12011-015-0495-0","volume":"171","author":"R Lei","year":"2016","unstructured":"Lei R, Jiang N, Zhang Q et al (2016) Prevalence of selenium, T-2 toxin, and deoxynivalenol in Kashin-Beck disease areas in Qinghai Province, Northwest China. Biol Trace Elem Res 171(1):34\u201340","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"33_CR110","doi-asserted-by":"publisher","first-page":"E719","DOI":"10.1210\/jc.2013-3539","volume":"99","author":"LR Santos","year":"2014","unstructured":"Santos LR, Dur\u00e3es C, Mendes A et al (2014) A polymorphismin the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto\u2019s thyroiditis susceptibility. J Clin Endocrinol Metab 99(4):E719\u2013E723","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"33_CR111","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/jhg.2015.42","volume":"60","author":"M Li","year":"2015","unstructured":"Li M, Liu B, Li L, Zhang C, Zhou Q (2015) Association studies of SEPS1 gene polymorphisms with Hashimoto\u2019s thyroiditis in Han Chinese. J Hum Genet 60(8):427\u2013433","journal-title":"J Hum Genet"},{"key":"33_CR112","doi-asserted-by":"publisher","unstructured":"Xiao L, Yuan J, Yao Q et al (2017) A case-control study of selenoprotein genes polymorphisms and autoimmune thyroid diseases in a Chinese population. BMC Med Genet. \n                    https:\/\/doi.org\/10.1186\/s12881-017-0415-6","DOI":"10.1186\/s12881-017-0415-6"},{"issue":"3","key":"33_CR113","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1530\/EJE-14-0302","volume":"171","author":"H Verloop","year":"2014","unstructured":"Verloop H, Dekkers OM, Peeters RP, Schoones JW, Smit JW (2014) Genetics in endocrinology: genetic variation in deiodinases: a systematic review of potential clinical effects in humans. Eur J Endocrinol 171(3):R123\u2013R135","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"33_CR114","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3945\/ajcn.112.043125","volume":"96","author":"JC Miller","year":"2012","unstructured":"Miller JC, Thomson CD, Williams SM et al (2012) Influence of the glutathione peroxidase 1 Pro200Leu polymorphism on the response of glutathione peroxidase activity to selenium supplementation: a randomized controlled trial. Am J Clin Nutr 96(4):923\u2013931","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"33_CR115","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3945\/ajcn.115.114231","volume":"103","author":"J Mao","year":"2016","unstructured":"Mao J, Vanderlelie JJ, Perkins AV, Redman CW, Ahmadi KR, Rayman MP (2016) Genetic polymorphisms that affect selenium status and response to selenium supplementation in United Kingdom pregnant women. Am J Clin Nutr 103(1):100\u2013106","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"33_CR116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.gene.2013.10.035","volume":"534","author":"JN Hellwege","year":"2014","unstructured":"Hellwege JN, Palmer ND, Ziegler JT et al (2014) Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 534(1):33\u201339","journal-title":"Gene"},{"issue":"6","key":"33_CR117","doi-asserted-by":"publisher","first-page":"e65657","DOI":"10.1371\/journal.pone.0065657","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Yang X, Zheng Y et al (2013) The SEPS1 G-105A polymorphism is associated with risk of spontaneous preterm birth in a Chinese population. PLoS One 8(6):e65657. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0065657","journal-title":"PLoS One"},{"issue":"12","key":"33_CR118","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/mnfr.201300216","volume":"57","author":"LK Crosley","year":"2013","unstructured":"Crosley LK, Bashir S, Nicol F, Arthur JR, Hesketh JE, Sneddon AA (2013) The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. Mol Nutr Food Res 57(12):2185\u20132194","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"33_CR119","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MBC.0000000000000202","volume":"26","author":"XX Li","year":"2015","unstructured":"Li XX, Guan HJ, Liu JP et al (2015) Association of selenoprotein S gene polymorphism with ischemic stroke in a Chinese case-control study. Blood Coagul Fibrinolysis 26(2):131\u2013135","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"33_CR120","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/07435800.2015.1094084","volume":"41","author":"MK Kilic","year":"2016","unstructured":"Kilic MK, Yesilkaya Y, Tezcan K et al (2016) The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels among patients with euthyroid and hypothyroid goitrous and non-goitrous Hashimoto\u2019s thyroiditis versus healthy subjects. Endocr Res 41(2):110\u2013115","journal-title":"Endocr Res"},{"key":"33_CR121","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000452909","volume":"48","author":"F Felicetti","year":"2017","unstructured":"Felicetti F, Catalano MG, Fortunati N (2017) Thyroid autoimmunity and cancer. Front Horm Res 48:97\u2013109","journal-title":"Front Horm Res"},{"issue":"1","key":"33_CR122","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000371741","volume":"4","author":"E Fiore","year":"2015","unstructured":"Fiore E, Latrofa F, Vitti P (2015) Iodine, thyroid autoimmunity and cancer. Eur Thyroid J 4(1):26\u201335","journal-title":"Eur Thyroid J"},{"key":"33_CR123","doi-asserted-by":"crossref","unstructured":"Lipinski B (2016) Sodium selenite as an anti-cancer agent. Anticancer Agents Med Chem","DOI":"10.2174\/1871520616666160607011024"},{"issue":"5","key":"33_CR124","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3892\/mmr.2017.6377","volume":"15","author":"M Vinceti","year":"2017","unstructured":"Vinceti M, Filippini T, Cilloni S et al (2017) Health risk assessment of environmental selenium: emerging evidence and challenges. (Review) Mol Med Rep 15(5):3323\u20133335","journal-title":"(Review) Mol Med Rep"},{"issue":"5","key":"33_CR125","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.3390\/nu7053536","volume":"7","author":"S Misra","year":"2015","unstructured":"Misra S, Boylan M, Selvam A, Spallholz JE, Bj\u00f6rnstedt M (2015) Redox-active selenium compounds-from toxicity and cell death to cancer treatment. Nutrients 7(5):3536\u20133556","journal-title":"Nutrients"},{"issue":"2","key":"33_CR126","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/nu8020080","volume":"8","author":"AN Ogawa-Wong","year":"2016","unstructured":"Ogawa-Wong AN, Berry MJ, Seale LA (2016) Selenium and metabolic disorders: an emphasis on type 2 diabetes risk. Nutrients 8(2):80. \n                    https:\/\/doi.org\/10.3390\/nu8020080","journal-title":"Nutrients"},{"issue":"2","key":"33_CR127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/iub.1466","volume":"68","author":"JK Wrobel","year":"2016","unstructured":"Wrobel JK, Power R, Toborek M (2016) Biological activity of selenium: revisited. IUBMB Life 68(2):97\u2013105","journal-title":"IUBMB Life"},{"issue":"5","key":"33_CR128","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/MED.0000000000000190","volume":"22","author":"J K\u00f6hrle","year":"2015","unstructured":"K\u00f6hrle J (2015) Selenium and the thyroid. Curr Opin Endocrinol Diabetes Obes 22(5):392\u2013401","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"33_CR129","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3945\/an.116.013516","volume":"8","author":"L Schwingshackl","year":"2017","unstructured":"Schwingshackl L, Boeing H, Stelmach-Mardas M et al (2017) Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials. Adv Nutr 8(1):27\u201339","journal-title":"Adv Nutr"},{"key":"33_CR130","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13643-015-0029-z","volume":"4","author":"L Schwingshackl","year":"2015","unstructured":"Schwingshackl L, Hoffmann G, Buijsse B et al (2015) Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials. Syst Rev 4:34. \n                    https:\/\/doi.org\/10.1186\/s13643-015-0029-z","journal-title":"Syst Rev"},{"issue":"10 Suppl","key":"33_CR131","first-page":"21","volume":"36","author":"P Sabino","year":"2013","unstructured":"Sabino P, Stranges S, Strazzullo P (2013) Does selenium matter in cardiometabolic disorders? A short review of the evidence. J Endocrinol Investig 36(10 Suppl):21\u201327","journal-title":"J Endocrinol Investig"},{"key":"33_CR132","first-page":"CD009671","volume":"1","author":"K Rees","year":"2013","unstructured":"Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S (2013) Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 1:CD009671","journal-title":"Cochrane Database Syst Rev"},{"key":"33_CR133","doi-asserted-by":"publisher","first-page":"CD007176","DOI":"10.1002\/14651858.CD007176.pub2","volume":"3","author":"G Bjelakovic","year":"2012","unstructured":"Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2012) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 3:CD007176. \n                    https:\/\/doi.org\/10.1002\/14651858.CD007176.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"33_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jtemb.2014.11.006","volume":"31","author":"U Alehagen","year":"2015","unstructured":"Alehagen U, Aaseth J (2015) Selenium and coenzyme Q10 interrelationship in cardiovascular diseases\u2014a clinician\u2019s point of view. J Trace Elem Med Biol 31:157\u2013162","journal-title":"J Trace Elem Med Biol"},{"key":"33_CR135","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtemb.2014.04.009","volume":"31","author":"G Alfthan","year":"2015","unstructured":"Alfthan G, Eurola M, Selenium Working Group et al (2015) Effects of nationwide addition of selenium to fertilizers on foods, and animal and human health in Finland: from deficiency to optimal selenium status of the population. J Trace Elem Med Biol 31:142\u2013147","journal-title":"J Trace Elem Med Biol"},{"issue":"6","key":"33_CR136","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/jsfa.6372","volume":"94","author":"MJ Poblaciones","year":"2014","unstructured":"Poblaciones MJ, Rodrigo S, Santamaria O, Chen Y, McGrath SP (2014) Selenium accumulation and speciation in biofortified chickpea (Cicer arietinum L.) under Mediterranean conditions. J Sci Food Agric 94(6):1101\u20131106","journal-title":"J Sci Food Agric"},{"key":"33_CR137","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.foodchem.2016.07.015","volume":"214","author":"P Vita De","year":"2017","unstructured":"De Vita P, Platani C, Fragasso M et al (2017) Selenium-enriched durum wheat improves the nutritional profile of pasta without altering its organoleptic properties. Food Chem 214:374\u2013382","journal-title":"Food Chem"},{"key":"33_CR138","unstructured":"Lipinski B (2016) Redox-active selenium in health and disease: a conceptual review. Mini Rev Med Chem"},{"key":"33_CR139","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.foodchem.2013.09.070","volume":"146","author":"MJ Poblaciones","year":"2014","unstructured":"Poblaciones MJ, Rodrigo S, Santamar\u00eda O, Chen Y, McGrath SP (2014) Agronomic selenium biofortification in Triticum durum under Mediterranean conditions: from grain to cooked pasta. Food Chem 146:378\u2013384","journal-title":"Food Chem"},{"issue":"1","key":"33_CR140","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12011-012-9539-x","volume":"151","author":"MJ Poblaciones","year":"2013","unstructured":"Poblaciones MJ, Rodrigo SM, Santamar\u00eda O (2013) Evaluation of the potential of peas (Pisumsativum L.) to be used in selenium biofortification programs under Mediterranean conditions. Biol Trace Elem Res 151(1):132\u2013137","journal-title":"Biol Trace Elem Res"},{"issue":"6A","key":"33_CR141","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1017\/S1368980010001072","volume":"13","author":"P Pietinen","year":"2010","unstructured":"Pietinen P, M\u00e4nnist\u00f6 S, Valsta LM, Sarlio-L\u00e4hteenkorva S (2010) Nutrition policy in Finland. Public Health Nutr 13(6A):901\u2013906","journal-title":"Public Health Nutr"},{"issue":"12","key":"33_CR142","doi-asserted-by":"publisher","first-page":"824","DOI":"10.7326\/0003-4819-159-12-201312170-00729","volume":"159","author":"SP Fortmann","year":"2013","unstructured":"Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP (2013) Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 159(12):824\u2013834","journal-title":"Ann Intern Med"},{"issue":"23","key":"33_CR143","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.1039\/c3cs60272a","volume":"42","author":"CM Weekley","year":"2013","unstructured":"Weekley CM, Harris HH (2013) Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev 42(23):8870\u20138894","journal-title":"Chem Soc Rev"},{"issue":"2","key":"33_CR144","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5114\/aoms.2016.59271","volume":"12","author":"T Golabek","year":"2016","unstructured":"Golabek T, Bukowczan J, Sobczynski R, Leszczyszyn J, Chlosta PL (2016) The role of micronutrients in the risk of urinary tract cancer. Arch Med Sci 12(2):436\u2013447","journal-title":"Arch Med Sci"},{"issue":"5","key":"33_CR145","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/carcin\/bgu063","volume":"35","author":"JD Potter","year":"2014","unstructured":"Potter JD (2014) The failure of cancer chemoprevention. Carcinogenesis 35(5):974\u2013982","journal-title":"Carcinogenesis"},{"issue":"2","key":"33_CR146","doi-asserted-by":"publisher","first-page":"411","DOI":"10.5114\/aoms.2015.50973","volume":"11","author":"T Golabek","year":"2015","unstructured":"Golabek T, Powro\u017anik J, Ch\u0142osta P, Dobruch J, Bor\u00f3wka A (2015) The impact of nutrition in urogenital cancers. Arch Med Sci 11(2):411\u2013418","journal-title":"Arch Med Sci"},{"key":"33_CR147","doi-asserted-by":"publisher","first-page":"CD00418","DOI":"10.1002\/14651858.CD004183.pub3","volume":"3","author":"G Bjelakovic","year":"2008","unstructured":"Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2008) Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 3:CD00418. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004183.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"33_CR148","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1089\/ars.2010.3275","volume":"14","author":"SJ Fairweather-Tait","year":"2011","unstructured":"Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, Hurst R (2011) Selenium in human health and disease. Antioxid Redox Signal 14(7):1337\u20131383","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"33_CR149","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3945\/an.115.010785","volume":"7","author":"KS Prabhu","year":"2016","unstructured":"Prabhu KS, Lei XG (2016) Selenium. Adv Nutr 7(2):415\u2013417","journal-title":"Adv Nutr"},{"key":"33_CR150","doi-asserted-by":"publisher","first-page":"249125","DOI":"10.1155\/2015\/249125","volume":"2015","author":"J Barrio-Barrio","year":"2015","unstructured":"Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Vel\u00e1zquez-Villoria \u00c1, Galofr\u00e9 JC (2015) Graves\u2019 ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol 2015:249125. \n                    https:\/\/doi.org\/10.1155\/2015\/249125","journal-title":"J Ophthalmol"},{"key":"33_CR151","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K et al (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"issue":"12","key":"33_CR152","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ et al (2014) Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24(12):1670\u20131751","journal-title":"Thyroid"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0033-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T19:06:49Z","timestamp":1559675209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-018-0033-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":152,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["33"],"URL":"https:\/\/doi.org\/10.1007\/s42000-018-0033-5","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}